News tagged with cisplatin
Replication at DNA damage sites highlights Fanconi anemia and breast cancer proteins
Sep 10, 2009 |
not rated yet |
0
While Fanconi anemia (FA) is a rare and dangerous disease, new laboratory research at The University of Texas M. D. Anderson Cancer Center shows it may lead researchers toward clues in more common diseases, including highly ...
A more direct delivery of cancer drugs to tumors
Nanotechnology / Bio & Medicine
Apr 21, 2009 |
4.2 / 5 (5) |
0
(PhysOrg.com) -- An interdisciplinary team of researchers at Brigham and Women’s Hospital (BWH) and the Harvard-MIT Division of Health Sciences and Technology (HST) has demonstrated a better way to deliver ...
3-drug chemotherapy combination increases organ preservation in patients with larynx cancer
Mar 24, 2009 |
5 / 5 (1) |
0
Patients with larynx cancer who received a three-drug combination of docetaxel, cisplatin and 5-fluorouracil (TPF) during induction chemotherapy were more likely to retain larynx function than were patients treated with cisplatin ...
Search results for cisplatin
New platinum compound shows promise in tumor cells
Dec 07, 2009 |
4.8 / 5 (5) |
1
(PhysOrg.com) -- MIT chemists have developed a new platinum compound that is as powerful as the commonly used anticancer drug cisplatin but better able to destroy tumor cells.
Omega-3 kills cancer cells
Apr 02, 2009 |
4.6 / 5 (7) |
1
Docosahexanoic acid (DHA), an omega-3 fatty acid found in fish oils, has been shown to reduce the size of tumours and enhance the positive effects of the chemotherapy drug cisplatin, while limiting its harmful side effects. ...
Researchers Studying Model to Learn Why Certain Cancers Become Resistant to Drugs
Sep 21, 2007 |
4.7 / 5 (3) |
0
Resistance to chemotherapy treatments can be the worst news a cancer patient ever receives. A pair of researchers at the University of Missouri-Columbia is working steadfastly to learn why some tumors eventually build a tolerance ...
Researchers studying model to learn why certain cancers become resistant to drugs
Oct 02, 2007 |
4 / 5 (5) |
0
Resistance to chemotherapy treatments can be the worst news a cancer patient ever receives. A pair of researchers at the University of Missouri-Columbia is working steadfastly to learn why some tumors eventually build a tolerance ...
How Does the Antitumor Drug Get to the Cell Nucleus?
Oct 30, 2007 |
4.3 / 5 (3) |
0
Platinum complexes such as the well-known cisplatin are powerful antitumor medications. They cross the cell membrane and reach the nucleus, where they attach to DNA and stop cell growth. But how does cisplatin get to the ...
Variation of normal protein could be key to resistance to common cancer drug
Aug 28, 2008 |
4.7 / 5 (3) |
0
Researchers at the Moores Cancer Center at the University of California, San Diego (UC SD) in La Jolla have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient. ...
Light activated anticancer drug targeted to DNA using cisplatin like sub-units
Mar 27, 2006 |
5 / 5 (7) |
0
One of the most effective chemotherapy drugs against cancer is cisplatin because it attaches to cancer DNA and disrupts repair. However, it also kills healthy tissue. Many scientists are creating alternative drugs or cisplatin ...
Gold Nanoparticles Delivery Platinum Warheads to Tumors
Nanotechnology / Bio & Medicine
Oct 29, 2009 |
4.9 / 5 (7) |
2
(PhysOrg.com) -- Cisplatin is one of the most powerful and effective drugs for treating a wide variety of cancers, but serious side effects ultimately limit the drug's use and effectiveness. Now, however, researchers have ...
Metals could forge new cancer drug
Oct 19, 2009 |
4 / 5 (1) |
0
Drugs made using unusual metals could form an effective treatment against colon and ovarian cancer, including cancerous cells that have developed immunity to other drugs, according to research at the University ...
Precious metal could lead to next generation of cancer treatments
Dec 08, 2008 |
4.3 / 5 (6) |
0
A precious metal which has never before been used in a clinical setting is being developed as an anti-cancer agent by University of Warwick researchers.
List of search results for cisplatin
